M&A · Healthcare · Buyer's industry: Pharmaceutical Preparations
Millendo Therapeutics, Inc. to acquire Tempest
Announced Mar 29, 2021 · Closed Jun 28, 2021 · Private target
Deal value—
Premium—To unaffected price
EV / Adj. EBITDA—
ConsiderationAll stock
Transaction
- Acquirer
- Millendo Therapeutics, Inc. (MLND)
- Target
- Tempest
- Buyer type
- Strategic
- Offer price per share
- —
- Enterprise value
- —
- Status
- Closed Jun 28, 2021
Deal protections
Not disclosed for private-company acquisitions.
Advisors
- To the acquirer
- Leerink Partners
- To the target
- Piper Sandler
Classification
- Sector
- Healthcare
- Buyer's industry
- Pharmaceutical Preparations